Good evening :)
Anupam Rasayan India Ltd

Anupam Rasayan India Ltd

ANURAS Share Price

NSE
₹1,192.401.29% (+15.20)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹13,402 cr, stock is ranked 517

Stock is 1.92x as volatile as Nifty

ANURAS Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹13,402 cr, stock is ranked 517

Stock is 1.92x as volatile as Nifty

ANURAS Performance & Key Metrics

ANURAS Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
76.712.890.13%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
24.253.051.43%

ANURAS Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
63%
Analysts have suggested that investors can buy this stock

from 8 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

ANURAS Company Profile

Anupam Rasayan is engaged in the business of custom synthesis and manufacturing of specialty chemicals in India.

Investor Presentation

View older View older 

Aug 14, 2026

PDF
View Older Presentations

ANURAS Similar Stocks (Peers)

Compare with peers Compare with peers 

ANURAS Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
85.16
85.16
1Y Return
17.42%
17.42%
Buy Reco %
80.00
80.00
PE Ratio
65.42
65.42
1Y Return
80.76%
80.76%
Buy Reco %
78.57
78.57
PE Ratio
99.57
99.57
1Y Return
138.59%
138.59%
Buy Reco %
66.67
66.67
PE Ratio
42.37
42.37
1Y Return
28.61%
28.61%
Buy Reco %
84.21
84.21
PE Ratio
50.26
50.26
1Y Return
3.42%
3.42%
Buy Reco %
100.00
100.00
Compare with Peers

ANURAS Sentiment Analysis

ANURAS Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

ANURAS Stock Summary · May 2026

Strong FY26 growth and an acquisition‑led pivot toward pharma and high‑performance materials was the dominant message, with consolidated revenue rising to INR 2,384 crore and FY26 EBITDA of INR 543 crore (23% margin). Management emphasized a deliberate strategic shift away from agrochemicals into pharma, polymers, personal‑care and semiconductor/EV end markets, building a globally integrated specialty‑chemicals platform that leverages Tanfac for fluorination inputs, Jayhawk’s U.S. manufacturing and Bliss’s formulation accreditations to win multinational customers. The team framed acquisitions as catalytic—Jayhawk adds roughly US$76m in pro‑forma revenue and Bliss brings differentiated formulation and CDMO potential—while noting pro‑forma distortions from recent deals. Tensions discussed included higher gross/net debt (about INR 1,500 crore and net ~INR 1,100 crore, rising toward ~INR 1,400–1,500 crore post‑acquisition), long working‑capital days (~215–220 pro‑forma) and Bliss’s current ~30% utilization that must ramp. Management expects Bliss synergies to begin in 6–12 months and grow by ~18 months, described the Bliss deal as day‑one EPS accretive, and reiterated maintenance capex of ~INR 50–75 crore with regulatory approvals and open‑offer timing of ~2–3 months.

ANURAS Stock Growth Drivers
ANURAS Stock Growth Drivers
6
  • Record FY26 Financial Performance and Strong Cash Conversion

    The company delivered its highest-ever revenue in FY26 with consolidated revenue of INR 2,384 crore

  • Capex Completion and Available Capacity to Support Near‑Term Growth

    The final phase of the capex program was completed with INR 315 crore invested, bringing

ANURAS Stock Challenges
ANURAS Stock Challenges
6
  • Profitability and Margin Compression Despite Strong Revenue Growth

    Consolidated top-line growth has been strong but profitability metrics have weakened, indicating margin pressure. Q4

  • Low Capacity Utilization and Capex Timing/Justification Risk

    Operations are running well below potential capacity and planned capital expenditure lacks quantified revenue justification,

ANURAS Forecast

ANURAS Forecasts

Price

Revenue

Earnings

ANURAS

ANURAS

Income

Balance Sheet

Cash Flow

ANURAS Income Statement

ANURAS Income Statement

Loading...

Quartermar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026jun 2026
Total Revenue413.05260.27295.90386.59505.70490.74739.19514.55639.15667.55
Operating & Other expensessubtract308.33201.02213.54265.84355.70361.54595.61384.97498.49492.61
Depreciation/Amortizationsubtract20.7520.6521.6829.3030.6630.6832.0734.4742.6856.06
Interest & Other Itemssubtract26.0722.3826.6631.9631.2235.6735.9835.1641.9149.19
Taxes & Other Itemssubtract27.0012.3117.3531.3143.5428.8131.1410.9013.4331.05
EPS2.810.361.512.574.063.103.934.313.753.39

ANURAS Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2027FY 2027

Annual Report Pending

Investor Presentation

Aug 14PDF
FY 2026FY 2026

Annual report

PDF

Investor Presentation

May 23PDF
May 23PDF
Feb 14PDF
+3 more
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 23PDF
Feb 13PDF
Nov 14PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
 

ANURAS Stock Peers

ANURAS Past Performance & Peer Comparison

ANURAS Past Performance & Peer Comparison

Comparing 3 stocks from 
MaterialsSpecialty Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Anupam Rasayan India Ltd78.792.890.13%
Gujarat Fluorochemicals Ltd85.165.890.07%
Navin Fluorine International Ltd65.4210.920.10%
Aether Industries Limited99.578.90—

ANURAS Stock Price Comparison

Compare ANURAS with any stock or ETF
Compare ANURAS with any stock or ETF
ANURAS
Loading...

ANURAS Holdings

ANURAS Shareholdings

ANURAS Promoter Holdings Trend

ANURAS Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

ANURAS Institutional Holdings Trend

ANURAS Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

ANURAS Shareholding Pattern

ANURAS Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding59.07%0.19%0.19%7.71%32.83%

Sep 2025

Dec 2025

Mar 2026

Jun 2026

ANURAS Shareholding History

ANURAS Shareholding History

JunJulSepDec '25MarJun4.94%7.75%7.63%7.60%6.91%7.71%

Mutual Funds Invested in ANURAS

Mutual Funds Invested in ANURAS

No mutual funds holding trends are available

Top 5 Mutual Funds holding Anupam Rasayan India Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
0.1431%1.25%1.25%28/104 (+72)
0.0588%0.41%0.41%104/112 (+5)
0.0446%1.29%1.29%52/80 (+24)

Compare 3-month MF holding change on Screener

ANURAS Insider Trades & Bulk Stock Deals

ANURAS Insider Trades & Bulk Stock Deals

Loading...

smallcases containing ANURAS stock

smallcases containing ANURAS stock

Looks like this stock is not in any smallcase yet.

ANURAS Events

ANURAS Events

ANURAS Dividend Trend

No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

ANURAS has shown inconsistent dividend trend over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.13%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.27 every year

Dividends

Corp. Actions

Announcements

Legal Orders

ANURAS Dividend Trend

No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

ANURAS has shown inconsistent dividend trend over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.13%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.27 every year

ANURAS Upcoming Dividends

ANURAS Upcoming Dividends

No upcoming dividends are available

ANURAS Past Dividends

ANURAS Past Dividends

Cash Dividend

Ex DateEx DateSep 18, 2026

Final
Final | Div/Share: ₹1.50

Dividend/Share

₹1.50

Ex DateEx Date

Sep 18, 2026

Cash Dividend

Ex DateEx DateJul 21, 2025

Interim
Interim | Div/Share: ₹0.75

Dividend/Share

₹0.75

Ex DateEx Date

Jul 21, 2025

Cash Dividend

Ex DateEx DateSep 17, 2024

Final
Final | Div/Share: ₹0.75

Dividend/Share

₹0.75

Ex DateEx Date

Sep 17, 2024

Cash Dividend

Ex DateEx DateNov 20, 2023

Interim 1
Interim 1 | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Nov 20, 2023

Cash Dividend

Ex DateEx DateMay 15, 2023

Interim 3
Interim 3 | Div/Share: ₹1.50

Dividend/Share

₹1.50

Ex DateEx Date

May 15, 2023

ANURAS Stock News & Opinions

ANURAS Stock News & Opinions

Corporate
Corporate
Anupam Rasayan India Limited secures INR 145 Crores through debenture placement with Axis Bank

Anupam Rasayan India Limited has issued 14,500 non-convertible, secured debentures totaling INR 145 Crores (approximately $17.5 million USD) through a private placement to raise capital. The transaction, governed by Indian laws and regulations, is secured by a first-ranking charge on an escrow account held with Axis Bank Limited, providing significant protection for debenture holders. CTL Trusteeship Limited was appointed as the independent debenture trustee, representing the interests of investors and possessing powers to protect their investment, including the ability to take possession and sell assets in case of default. The debenture trustee is not related to Anupam Rasayan’s promoters and the engagement was conducted at arm’s length, minimizing potential conflicts of interest.

5 days agoCapital Market - Live
Spotlight
Spotlight
Volumes soar at Anupam Rasayan India Ltd counter

Carborundum Universal Ltd, Jaiprakash Power Ventures Ltd, Fertilizers & Chemicals Travancore Ltd, Cohance Lifesciences Ltd are among the other stocks to see a surge in volumes on NSE today, 21 September 2026.Anupam Rasayan India Ltd recorded volume of 56.72 lakh shares by 14:24 IST on NSE, a 18.4 times surge over two-week average daily volume of 3.08 lakh shares. The stock lost 2.20% to Rs.1,181.10. Volumes stood at 4.65 lakh shares in the last session.Carborundum Universal Ltd notched up volume of 33.59 lakh shares by 14:24 IST on NSE, a 17.34 fold spurt over two-week average daily volume of 1.94 lakh shares. The stock rose 3.52% to Rs.1,164.00. Volumes stood at 5.33 lakh shares in the last session.Jaiprakash Power Ventures Ltd clocked volume of 5026.89 lakh shares by 14:24 IST on NSE, a 14.22 times surge over two-week average daily volume of 353.59 lakh shares. The stock gained 9.11% to Rs.16.77. Volumes stood at 373.04 lakh shares in the last session.Fertilizers & Chemicals Travancore Ltd saw volume of 10.85 lakh shares by 14:24 IST on NSE, a 7.61 fold spurt over two-week average daily volume of 1.43 lakh shares. The stock increased 3.96% to Rs.794.50. Volumes stood at 66764 shares in the last session.Cohance Lifesciences Ltd notched up volume of 66.59 lakh shares by 14:24 IST on NSE, a 7.08 fold spurt over two-week average daily volume of 9.41 lakh shares. The stock rose 7.58% to Rs.471.20. Volumes stood at 6.99 lakh shares in the last session.

6 days agoCapital Market - Live
Corporate
Corporate
Anupam Rasayan secures INR 160 crore in debentures from Aditya Birla Capital

Anupam Rasayan India Limited announced that its board approved the issuance of up to 16,000 INR denominated, secured, rated, unlisted, and redeemable non-convertible debentures with a nominal value of INR 100,000 each, aggregating to not more than INR 160 crore, on a private placement basis to Aditya Birla Capital Limited. The proceeds will be used for repayment of existing debt facilities and/or investment in group companies and/or for general corporate purposes, and the debentures will be secured by a pledge over certain shares and a hypothecation over an escrow account with Axis Bank Limited.

1 week agoCapital Market - Live
Corporate
Corporate
Anupam Rasayan’s subsidiary secures Rs 300 crore in debentures, with Purebliss as potential stakeholder

Anupam Rasayan India Limited announced that its board approved the execution of transaction and security documents related to financing being availed by its wholly-owned subsidiary, Mates Visa Consultancy Private Limited, which plans to issue up to 30,000 senior secured redeemable non-convertible debentures with a face value of Rs 100,000 each, totaling up to Rs 300 crore, on a private placement basis. The board also approved a corporate guarantee by Anupam Rasayan to secure the debentures and a call option agreement with Purebliss Pharma Solutions Private Limited, whereby Anupam Rasayan may grant Purebliss an option to purchase a 15% stake in Purebliss.

1 week agoCapital Market - Live
Corporate
Corporate
Anupam Rasayan India to seek board approval for Rs 160 crore debenture fundraising

Anupam Rasayan India Limited will hold a board meeting on September 19, 2026, to consider and approve a fund raising of up to Rs 160,00,00,000 through the issuance of secured, rated, unlisted, redeemable, non-convertible debentures on a private placement basis.

1 week agoCapital Market - Live
Corporate
Corporate
Anupam Rasayan acquired a significant stake in Tanfac Industries via a preferential share issue

Anupam Rasayan India Limited has acquired 2,60,065 equity shares in Tanfac Industries Limited through a preferential issue for an aggregate consideration of Rs 60,88,12,165, as announced on September 9, 2026.

2 weeks agoCapital Market - Live
Corporate
Corporate
Anupam Rasayan to acquire 2,60,065 shares of Tanfac Industries for Rs 60.88 crore

Anupam Rasayan India Limited announced that its board approved the acquisition of 2,60,065 equity shares of Tanfac Industries Limited on a preferential issue basis for an aggregate consideration of Rs 60,88,12,165, or Rs 2,341 per share. The acquisition aims to increase Anupam Rasayan’s shareholding in Tanfac Industries Limited, which was passively diluted due to a qualified institutional placement, and Tanfac Industries Limited is a joint sector company promoted by Anupam Rasayan India Limited and the Tamil Nadu Industrial Development Corporation (TIDCO).

2 weeks agoCapital Market - Live
Corporate
Corporate
Anupam Rasayan sets September 18, 2026, as record date for final dividend

Anupam Rasayan India Limited has fixed September 18, 2026, as the record date for the final dividend for the financial year 2025-26, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited on September 7, 2026, with payment expected on or before October 29, 2026, following approval by shareholders at the company’s 23rd Annual General Meeting.

2 weeks agoCapital Market - Live
Corporate
Corporate
Anupam Rasayan appoints Hetvi Vyas as Deputy CFO, effective September 2026

Anupam Rasayan India Limited announced the appointment of Ms. Hetvi Vyas as Deputy Chief Financial Officer and Key Managerial Personnel, effective September 8, 2026, following a recommendation from the Nomination and Remuneration Committee.

2 weeks agoCapital Market - Live
Corporate
Corporate
Anupam Rasayan to acquire 2,60,065 shares of Tanfac Industries for Rs 60.88 crore

Anupam Rasayan India Limited announced that its board approved the acquisition of 2,60,065 equity shares of Tanfac Industries Limited on a preferential basis for a total consideration of Rs 60,88,12,165, with each share acquired at a price of Rs 2,341. The board also approved the notice for the company's 23rd Annual General Meeting to be held on September 30, 2026, fixed a record date of September 18, 2026, for a potential final dividend, and appointed Ms. Hetvi Vyas as Deputy Chief Financial Officer and Key Managerial Personnel.

2 weeks agoCapital Market - Live

Frequently asked questions

  1. The share price of ANURAS as on 25th September 2026 is ₹1192.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of Anupam Rasayan India Ltd (ANURAS) share are
    • Past 1 week: 0.06%
    • Past 1 month: -5.79%
    • Past 3 months: -6.49%
    • Past 6 months: -5.89%
    • Past 1 year: 7.93%
    • Past 3 years: 35.06%
    • Past 5 years: 49.47%

  3. The current dividend yield of Anupam Rasayan India Ltd (ANURAS) is 0.13.

  4. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Anupam Rasayan India Ltd (ANURAS) is ₹13402.40 Cr as of 25th September 2026.

  5. The 52-week high of Anupam Rasayan India Ltd (ANURAS) is ₹1415 and the 52-week low is ₹1045.20.

  6. The P/E (price-to-earnings) ratio of Anupam Rasayan India Ltd (ANURAS) is 78.79. The P/B (price-to-book) ratio is 2.89.

  7. Anupam Rasayan India Ltd (ANURAS) belongs to the Materials sector & Specialty Chemicals sub-sector.

  8. You can directly buy Anupam Rasayan India Ltd (ANURAS) shares on Tickertape. Simply sign up, connect your demat account and place your order.